Skip to content
Markets
This is research, not advice. We’re not SEBI-registered.

Healthcare Services Stocks and Companies in India

No healthcare services has a 🤑 or 🚀 tag · 8 of 8 beat the NIFTY 500 over 3 years, or since listing for a newer company

By market cap🤑 Deep value (our tag): share price grew slower than profit and sales over 3 to 5 years, returns not falling🚀 Speeding up: profit and sales growth and the price all quickeningNo company carries either mark on this pageRank = our Deep value score: business 50 + speed-up 30 + lag 20
Share price, services index and NIFTY 5001Y to 10Y

Unihealth Hospitals leads at +284%; 8 of 8 beat the NIFTY 500

No 🚀 or 🤑 company among those picked

Since 17 Nov 2023+154% services indexMedian company +41.0% · NIFTY 500 +34.8%
Median company +41.0%
1Nephrocare Health Services+45.0%
2Gujarat Kidney & Super Speciality+51.6%
3KRM Ayurveda+33.4%
4Unihealth Hospitals+284%
5Dr Agarwals Health Care+37.0%
6Park Medi World+65.0%
7Credent Connect N Care+28.7%
8Gaudium IVF and Women Health+11.6%
Median company +41.0%
1Nephrocare Health Services+45.0%
2Gujarat Kidney & Super Speciality+51.6%
3KRM Ayurveda+33.4%
4Unihealth Hospitals+284%
5Dr Agarwals Health Care+37.0%
6Park Medi World+65.0%
7Credent Connect N Care+28.7%
8Gaudium IVF and Women Health+11.6%
Services index, all 8 companies at equal weight: 1Y change, then growth a year1Y+110.2%3Y+36.4%/yr5Y+24.7%/yr10YToo short
Services index (equal weight)NIFTY 500Companies: colours as the chips aboveRanked by our score; bars show each company's price change, a later listing from its first close; dashed line: the median company. Bar lengths are squeezed so the small moves stay visible next to the largest

EPS growth, TTM1Y to 10Y

Gaudium IVF and Women Health leads at +14.5% a year over 3 years; 2 of 2 grew

No 🚀 or 🤑 company among those picked

TTM, mostly to Sep 2026+8.0% a year, median EPS growth over 3 years5 companies, latest each
Last 12 monthsMedian +8.0%/yr
1Nephrocare Health Servicesn/a+89.2%
2Gujarat Kidney & Super Specialityn/a
3KRM Ayurvedan/a+339%
4Unihealth Hospitalsn/a
5Dr Agarwals Health Caren/a+49.5%
6Park Medi World+1.6%/yr+2.6%
7Credent Connect N Caren/a
8Gaudium IVF and Women Health+14.5%/yr−9.9%
Last 12 monthsMedian +8.0%/yr
1Nephrocare Health Servicesn/a+89.2%
2Gujarat Kidney & Super Specialityn/a
3KRM Ayurvedan/a+339%
4Unihealth Hospitalsn/a
5Dr Agarwals Health Caren/a+49.5%
6Park Medi World+1.6%/yr+2.6%
7Credent Connect N Caren/a
8Gaudium IVF and Women Health+14.5%/yr−9.9%
MedianNow, Sep 26+2.6%Mar 25+88.6%Sep 23Too shortSep 21Too short
Median of pickedLines: 3-quarter average (headline and bars: latest actual)Dotted: no figure that dateBars: latest TTM growth, ranked by our score. Right column: growth a year (3Y and longer)

Revenue growth, TTM1Y to 10Y

Unihealth Hospitals leads at +44.2% a year over 3 years; 6 of 6 grew

No 🚀 or 🤑 company among those picked

TTM, mostly to Sep 2026+25.2% a year, median revenue growth over 3 years7 companies, latest each
Last 12 monthsMedian +25.2%/yr
1Nephrocare Health Services+31.7%/yr+24.8%
2Gujarat Kidney & Super Specialityn/a+154%
3KRM Ayurveda+4.7%/yr+32.5%
4Unihealth Hospitals+44.2%/yr+33.3%
5Dr Agarwals Health Care+26.9%/yr+25.9%
6Park Medi World+10.2%/yr+22.9%
7Credent Connect N Caren/a
8Gaudium IVF and Women Health+23.6%/yr+22.9%
Last 12 monthsMedian +25.2%/yr
1Nephrocare Health Services+31.7%/yr+24.8%
2Gujarat Kidney & Super Specialityn/a+154%
3KRM Ayurveda+4.7%/yr+32.5%
4Unihealth Hospitals+44.2%/yr+33.3%
5Dr Agarwals Health Care+26.9%/yr+25.9%
6Park Medi World+10.2%/yr+22.9%
7Credent Connect N Caren/a
8Gaudium IVF and Women Health+23.6%/yr+22.9%
MedianNow, Sep 26+24.8%Mar 25+33.6%Mar 23+18.9%Sep 21Too short
Median of pickedLines: 3-quarter average (headline and bars: latest actual)Dotted: no figure that dateBars: latest TTM growth, ranked by our score. Right column: growth a year (3Y and longer)

ROCE, TTM1Y to 10Y

KRM Ayurveda leads at 35.5%; lowest Dr Agarwals Health Care 12.2%

No 🚀 or 🤑 company among those picked

TTM, mostly to Sep 202617.9% median ROCE7 companies, latest each
Median 17.9%
1Nephrocare Health Services14.2%
2Gujarat Kidney & Super Speciality16.2%
3KRM Ayurveda35.5%
4Unihealth Hospitals24.0%
5Dr Agarwals Health Care12.2%
6Park Medi World17.9%
7Credent Connect N Caren/a
8Gaudium IVF and Women Health25.2%
Median 17.9%
1Nephrocare Health Services14.2%
2Gujarat Kidney & Super Speciality16.2%
3KRM Ayurveda35.5%
4Unihealth Hospitals24.0%
5Dr Agarwals Health Care12.2%
6Park Medi World17.9%
7Credent Connect N Caren/a
8Gaudium IVF and Women Health25.2%
MedianNow, Sep 2616.2%Mar 2525.0%Mar 2322.0%Sep 21Too short
Median of pickedLines: yearly figuresDotted: no figure that dateBars: latest TTM figure, ranked by our score

🤑 Deep value (our tag): share price grew slower than profit and sales over 3 to 5 years, returns not falling

🚀 Speeding up: profit and sales growth and the price all quickening

Rank = our Deep value score: business 50 + speed-up 30 + lag 20

Industry · 8 companies

There are 8 listed Healthcare Services stocks in India. The largest by market value are Dr Agarwals Health Care (₹17,545 crore), Park Medi World (₹10,275 crore), Nephrocare Health Services (₹6,595 crore), Gujarat Kidney & Super Speciality and Unihealth Hospitals, at prices of 20 November 2026. 1 of the 8 companies we track is beating the Nifty 500 on share price over recent months (6 have no relative-strength reading yet).

Healthcare Services: Dr Agarwals Health Care Ltd owns the largest revenue base; Gujarat Kidney & Super Speciality Ltd has the fastest current growth.

The main question: the biggest companies are not always the ones changing the most.

Start with size. Then the direction of earnings. Then the quality of the business. A share price that leads means more once those three agree.

How big is the Healthcare Services sector?

There are 8 listed Healthcare Services companies on this page, worth ₹38,500 cr together at prices of 20 November 2026. Dr Agarwals Health Care alone is ₹17,500 cr, about 46% of the total.

8Companies every listed company in this industry
₹38,500 crCombined market value all of them together
5/5Revenue growing revenue over the last 12 months up on a year earlier
1/8Beating NIFTY 500 pass the weekly momentum test: 5+ points ahead over 3 months, within 20% of the 52-week high (6 have no reading yet)
1 of 8 pass the weekly momentum test (5+ points ahead of the NIFTY 500 over 3 months, within 20% of the 52-week high)

Market values at prices of 20 November 2026.

What did Healthcare Services managements say about July to September 2026?

7 of 8 Hospitals/Medical Services companies held a results call for July to September 2026. Gaudium IVF and Women Health guided: FY27 revenue ₹130 crore reaffirmed with hub rollout on schedule and stronger H2 expected.

Gaudium IVF and Women Health call 16 November 2026

“Historically, our new hubs have broken even within about 3-6 months of launch, and I am happy to share that South Extension is also almost breaking even within just the first 2.5 months of its launch.”Dr Manika Khanna

Guided: FY27 revenue ₹130 crore reaffirmed with hub rollout on schedule and stronger H2 expected.

Park Medi World call 14 November 2026

“The company currently has 2,300 beds under execution, which are expected to become operational by December 2028, taking the total bed capacity to 6,590 beds from 4,290 beds as of September 30, 2026.”Rajesh Sharma, Group CFO

Guided: FY27 revenue close to ₹2,050 crore with H2-weighted ramp.

Paras Healthcare call 6 November 2026

“Kanpur and Srinagar are now profitable at the EBITDA level. That has happened faster than at our earlier hospitals, and it is clearly demonstrating a playbook that can be repeated many times.”Dharmender Kumar Nagar

Guided: Add 200-250 beds across Kanpur and Ranchi in H2 to reach about 1800 operational beds.

Dr Agarwals Health Care call 5 November 2026

“We will be revising our capex guidance upwards from 400 to 500 crores.”Dr. Adil Agarwal

Guided: 65 facilities in FY27 including 55 surgical with 26 including 21 surgical in H2.

Gujarat Kidney & Super Speciality call 5 November 2026

“Our EBITDA margin of 32.8% was the best among our listed peers, against an average of approximately 24.3%.”Dr. Pragnesh Varpoda

Guided: FY27 average operating margin to stay around current level despite quarterly fluctuation.

Nephrocare Health Services call 4 November 2026

“If we lower our return thresholds by 5%, we would probably add another 30 to 40 clinics, or another 60 to 70 clinics per year. But what is the point of growing with such low ROCE returns?”Rohit Singh

Guided: Revenue yearly growth 15-20% over next 3-4 years - reiterated, prepared, range, no annual guide.

Credent Connect N Care call 29 October 2026

“If they handle this themselves, it is a fixed cost for them to expand, which does not provide them with operating leverage. Through us, they obtain a variable cost model with leverage as they expand into new cities.”Tarun Sharma

Guided: FY27 revenue ₹320 crore plus with growth cadence weighted to seasonally stronger H2.

From the results calls for July to September 2026.

Is money moving into Healthcare Services stocks? Who is adding capacity?

Big funds, foreign and Indian, cut their stake by 1.4 points over the last two quarters. Founders and promoters cut theirs by 0.7 points.

  • Spending on new plants and equipment was ₹1,367 crore in the last 12 months, 34% more than a year before.
  • Projects still being built grew 84% in a year.
  • 3 Hospitals/Medical Services calls in the last quarters talked about adding capacity.

Big funds = foreign and Indian institutions, change in their share of ownership across 7 Hospitals/Medical Services companies, in percentage points.

Ownership and spending as of 10 October 2026.

What to watch next in Healthcare Services stocks?

Equally, institutions continuing to flee (fii dii delta deepening below the current −1.74pp) while the capital spending/CWIP supply floods in would confirm CAPACITY RISK over growth.

From our industry review of 10 October 2026.

Which are the biggest Healthcare Services stocks in India?

The largest Healthcare Services stocks in India by market value are Dr Agarwals Health Care (₹17,545 crore), Park Medi World (₹10,275 crore) and Nephrocare Health Services (₹6,595 crore), at prices of 20 Nov 2026.

Share price | market value | P/E, biggest first. Prices, market values and ratios at the official close of 20 Nov 2026; the score list below uses the weekly figures.

Which are the Healthcare Services stocks, ranked?

Ranked by the 4-Factor Sector Score (growth & earnings 35, capital efficiency 25, valuation 20, relative strength 20). The scores come from our weekly scan.

  1. 1Dr Agarwals Health Care LtdAGARWALEYE · ₹17,500 cr58.9of 100mixed, leaning good · strongest on profit growth and ROCE improvement
  2. 2Gujarat Kidney & Super Speciality LtdGKSL · ₹1,180 cr50.5of 100mixed, leaning good · strongest on profit growth and revenue growth
  3. 3Park Medi World LtdPARKHOSPS · ₹10,300 cr48.5of 100provisional · strongest on ROCE improvement and profitable quarters
  4. 4Gaudium IVF and Women Health LtdGAUDIUMIVF · ₹725 cr46.1of 100mixed, leaning weak · strongest on ROCE and operating margin
  5. 5Nephrocare Health Services LtdNEPHROPLUS · ₹6,600 cr44.4of 100mixed, leaning weak · strongest on PEG and revenue growth
  6. 6KRM Ayurveda LtdKRMAYURVED · ₹468 cr64.4of 100provisional · strongest on ROCE and margin improvement
  7. 7Unihealth Hospitals LtdUNIHEALTH · ₹844 cr53.5of 100provisional · strongest on ROCE and relative strength versus the benchmark
  8. 8Credent Connect N Care LtdCREDENT · ₹824 cr50.5of 100provisional · strongest on ROCE and margin improvement

Is there a Nifty Healthcare Services index, and what is in it?

All 8 listed Indian Hospitals/Medical Services companies are named here, largest first. This is the set of companies people mean when they search for a Nifty Hospitals/Medical Services index; the exchange publishes its own indices only for the largest sectors, so this equal-weighted set stands in for one. Every figure is equal-weighted across those companies and carries its own as-of date.

  1. Dr Agarwals Health Care Ltd₹17,500 cr
  2. Park Medi World Ltd₹10,300 cr
  3. Nephrocare Health Services Ltd₹6,600 cr
  4. Gujarat Kidney & Super Speciality Ltd₹1,180 cr
  5. Unihealth Hospitals Ltd₹844 cr
  6. Gaudium IVF and Women Health Ltd₹725 cr
  7. Credent Connect N Care Ltd₹824 cr
  8. KRM Ayurveda Ltd₹468 cr

How many Healthcare Services companies are listed in India?

7 Healthcare Services companies in the Hospitals/Medical Services industry group have a page on Sector Alpha, and all 7 are listed below, largest first. The largest is Dr Agarwals Health Care (₹17,545 crore) and the smallest with a market value is KRM Ayurveda.

Every Hospitals/Medical Services company with a page, largest first
CompanyMarket value
1. Dr Agarwals Health Care Ltd AGARWALEYE₹17,545 crore
2. Park Medi World Ltd PARKHOSPS₹10,275 crore
3. Nephrocare Health Services Ltd NEPHROPLUS₹6,595 crore
4. Gujarat Kidney & Super Speciality Ltd GKSL₹1,177 crore
5. Unihealth Hospitals Ltd UNIHEALTH₹844 crore
6. Gaudium IVF and Women Health Ltd GAUDIUMIVF₹725 crore
7. KRM Ayurveda Ltd KRMAYURVED₹468 crore

Download all 7 Healthcare Services companies (CSV)

How have Healthcare Services stocks moved against NIFTY 500?

The line below covers up to 3.2 years and opens on the 3Y view; the buttons cut it shorter. Over the last two years (104 weeks) this sector is 171% ahead of NIFTY 500. Earnings across its companies grew 3% on average over the last four reported quarters, close to flat.

Basing · +0 joined ~

Price up, without the fundamentals confirming. 1 of the 6 companies with a long enough price record pass the momentum test (5+ points ahead of the Nifty 500 over 3 months, within 20% of the 52-week high).

Not ahead of NIFTY 500 on the three-month view this week; 4 of the 6 companies in the industry index above their 200-day average (2 more than four weeks earlier); 1 of those 6 pass the momentum test (no change from four weeks earlier); earnings rising at 3 of the 5 that report earnings.

Not ahead of NIFTY 500 yet, but 0 more stocks joined in four weeks, 1 → 1 of 6. Earnings mixed, 3 of 5 members have higher trailing twelve-month earnings than a year ago.

1Y

Hospitals/Medical Services against NIFTY 500

Both lines start at 200 in the first week shown

  • Healthcare Services 318
  • NIFTY 500 200
Hospitals/Medical Services against NIFTY 500
Week endingHealthcare ServicesNIFTY 500
21 Nov 2025200200
28 Nov 2025213201
5 Dec 2025193200
12 Dec 2025199199
19 Dec 2025197199
26 Dec 2025192200
2 Jan 2026200203
9 Jan 2026199197
16 Jan 2026199197
23 Jan 2026194191
30 Jan 2026198194
6 Feb 2026203197
13 Feb 2026211196
20 Feb 2026215197
27 Feb 2026223195
6 Mar 2026219189
13 Mar 2026218180
20 Mar 2026221179
27 Mar 2026216177
3 Apr 2026219176
10 Apr 2026241188
17 Apr 2026250192
24 Apr 2026263190
1 May 2026264191
8 May 2026270194
15 May 2026275189
22 May 2026283190
29 May 2026284190
5 Jun 2026283189
12 Jun 2026283190
19 Jun 2026298195
26 Jun 2026297194
3 Jul 2026308196
10 Jul 2026316196
17 Jul 2026320196
24 Jul 2026333193
31 Jul 2026327197
7 Aug 2026338199
14 Aug 2026322198
21 Aug 2026328198
28 Aug 2026332198
4 Sep 2026330195
11 Sep 2026338192
18 Sep 2026337192
25 Sep 2026336190
2 Oct 2026324184
9 Oct 2026314184
16 Oct 2026301187
23 Oct 2026283180
30 Oct 2026306184
6 Nov 2026316197
13 Nov 2026318200

3Y

Hospitals/Medical Services against NIFTY 500

Both lines start at 200 in the first week shown, every 2nd week shown

  • Healthcare Services 621
  • NIFTY 500 269
Hospitals/Medical Services against NIFTY 500
Week endingHealthcare ServicesNIFTY 500
24 Nov 2023200200
1 Dec 2023194205
15 Dec 2023196217
29 Dec 2023190220
12 Jan 2024215224
26 Jan 2024239220
9 Feb 2024229226
23 Feb 2024221230
8 Mar 2024214232
22 Mar 2024195227
5 Apr 2024198235
19 Apr 2024198231
3 May 2024182238
17 May 2024193239
31 May 2024184239
14 Jun 2024183252
28 Jun 2024177256
12 Jul 2024186262
26 Jul 2024179264
9 Aug 2024191260
23 Aug 2024208265
6 Sep 2024241266
20 Sep 2024225274
4 Oct 2024229267
18 Oct 2024229266
1 Nov 2024249259
15 Nov 2024222249
29 Nov 2024226257
13 Dec 2024229265
27 Dec 2024218254
10 Jan 2025217247
24 Jan 2025217242
7 Feb 2025215245
21 Feb 2025219235
7 Mar 2025215232
21 Mar 2025225241
4 Apr 2025224236
18 Apr 2025214246
2 May 2025215249
16 May 2025223259
30 May 2025216258
13 Jun 2025236260
27 Jun 2025235268
11 Jul 2025245264
25 Jul 2025253261
8 Aug 2025243254
22 Aug 2025249261
5 Sep 2025245259
19 Sep 2025255266
3 Oct 2025263261
17 Oct 2025272268
31 Oct 2025268269
14 Nov 2025270270
28 Nov 2025415271
12 Dec 2025389269
26 Dec 2025374270
9 Jan 2026389266
23 Jan 2026379257
6 Feb 2026396266
20 Feb 2026420265
6 Mar 2026428255
20 Mar 2026433242
3 Apr 2026428237
17 Apr 2026489259
1 May 2026516257
15 May 2026537255
29 May 2026554257
12 Jun 2026552256
26 Jun 2026581262
10 Jul 2026618265
24 Jul 2026650260
7 Aug 2026660269
21 Aug 2026640267
4 Sep 2026645264
18 Sep 2026658259
2 Oct 2026633248
16 Oct 2026587252
30 Oct 2026598248
13 Nov 2026621269

Earnings, each company rebased to 100, the sector takes the median

Latest quarter July to September 2026: 102.6, from 5 companies

Earnings, each company rebased to 100, the sector takes the median
QuarterMedian earnings index
Jul 2025100.0 (5 companies)
Oct 202599.7 (5 companies)
Jan 2026108.8 (6 companies)
Apr 2026104.4 (5 companies)
Jul 2026102.6 (5 companies)

Both lines start at 200 in the same week, so the gap between them tells the story: the sector line is an equal-weighted index of 6 of its 8 companies (the 2 with too short a price record are ranked in the scorecard but cannot sit in this line). The bars underneath are trailing 12-month earnings per share, one bar per reported quarter, each member set to 100 at the start and the sector taking the middle value, so a price line pulling away from flat bars means the market is paying more for the same earnings. A bar turns grey when that figure is lower than the quarter before. The rules are fixed and the same everywhere on this site: ahead by 5% or more over three months, or behind by 20% or more over a year while earnings grew 20% or more. Hover or tap any point to read both values and the gap.

Are Healthcare Services stocks outperforming NIFTY 500?

Hospitals/Medical Services has done better than the NIFTY 500 by 106.6% over the last 52 weeks. Over 13 weeks the gap is a shortfall of 5.7%. Unihealth Hospitals Ltd is the strongest against the sector itself at −0.7%. Readings are as of 13 November 2026.

−5.7%Sector vs NIFTY 500 · 13 weeks
+106.6%Sector vs NIFTY 500 · 52 weeks
1 of 8Stocks leading NIFTY 500

Relative-strength score for the industry: 8.1 as of 13 November 2026 (leaders, rising).

What is the bottom line on Healthcare Services stocks?

Hospitals/Medical Services has done better than the NIFTY 500 by 106.6% over 52 weeks, but is 5.7% behind over the last 13 weeks. 1 of 8 companies we track is beating the NIFTY on relative strength (how a share price has done against the index over recent months) (6 have no relative-strength reading yet).

How does each Healthcare Services stock score?

A score that ranks each company against the others in its industry. The four parts shown always add up to the total: Growth & earnings (35), Capital efficiency (25), Valuation (20), and Relative strength (20). Missing or old evidence affects only its own part, never as a hidden adjustment.

Growth & earnings · 35% Capital efficiency · 25% Valuation · 20% Relative strength · 20%

Dr Agarwals Health Care Ltd has the strongest current balance of earnings trajectory, business quality, valuation and price confirmation, with 60.3% evidence confidence.

  1. 1Dr Agarwals Health Care LtdAGARWALEYE · turning · mixed, leaning good · 60% evidence58.9out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 28.6/35 · Revenue 25.9% · PAT 42.1% · OPM change 0 pp · 95% evidenceCapital efficiency 9.3/25 · ROCE 10.9% (year to Mar 2026) · OPM 26.9% · 76% evidenceValuation 8.5/20 · P/E 97.4× · PEG — · 15% evidenceRelative strength 12.5/20 · RS sector — · RS bench 11.5% · 1Y 12.1% · 25% evidence · 9 of 12 weeks aheadExact sum: 28.6 + 9.3 + 8.5 + 12.5 = 58.9 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
  2. 2Gujarat Kidney & Super Speciality LtdGKSL · breaking out · mixed, leaning good · 63% evidence50.5out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 23.8/43.75 · Revenue 100% · PAT 68.2% · OPM change −12.8 pp · 100% evidenceCapital efficiency 15.5/31.25 · ROCE 14.5% (year to Mar 2026) · OPM 26.8% · 100% evidenceValuation 11.2/25 · P/E 61.9× · PEG — · 15% evidenceRelative strength: no reading this week · its 20 points are shared across the other threeExact sum: 23.8 + 15.5 + 11.2 = 50.5 (no relative-strength reading this week; its 20 points are shared across the other three) · What this means: There is no relative-strength reading for this week, so the score is built from earnings, capital efficiency and valuation alone.
  3. 3Park Medi World LtdPARKHOSPS · quiet · provisional · 55% evidence48.5out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 19.0/43.75 · Revenue 22.9% · PAT 12.3% · OPM change −7 pp · 95% evidenceCapital efficiency 17.3/31.25 · ROCE 19.5% (year to Mar 2026) · OPM 20% · 76% evidenceValuation 12.2/25 · P/E 40.1× · PEG — · 15% evidenceRelative strength: no reading this week · its 20 points are shared across the other threeExact sum: 19 + 17.3 + 12.2 = 48.5 (no relative-strength reading this week; its 20 points are shared across the other three) · What this means: Some evidence is missing, so the score is pulled toward the middle on purpose.
  4. 4Gaudium IVF and Women Health LtdGAUDIUMIVF · quiet · mixed, leaning weak · 63% evidence46.1out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 9.5/43.75 · Revenue 22.9% · PAT 3.9% · OPM change −7.4 pp · 100% evidenceCapital efficiency 22.8/31.25 · ROCE 29.5% (year to Mar 2026) · OPM 36% · 100% evidenceValuation 13.8/25 · P/E 30.4× · PEG — · 15% evidenceRelative strength: no reading this week · its 20 points are shared across the other threeExact sum: 9.5 + 22.8 + 13.8 = 46.1 (no relative-strength reading this week; its 20 points are shared across the other three) · What this means: There is no relative-strength reading for this week, so the score is built from earnings, capital efficiency and valuation alone.
  5. 5Nephrocare Health Services LtdNEPHROPLUS · quiet · mixed, leaning weak · 64% evidence44.4out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 19.2/43.75 · Revenue 24.8% · PAT 100% · OPM change −5 pp · 74% evidenceCapital efficiency 10.5/31.25 · ROCE 15.3% (year to Mar 2026) · OPM 20.8% · 100% evidenceValuation 14.7/25 · P/E 51.4× · PEG 1.22 · 65% evidenceRelative strength: no reading this week · its 20 points are shared across the other threeExact sum: 19.2 + 10.5 + 14.7 = 44.4 (no relative-strength reading this week; its 20 points are shared across the other three) · What this means: There is no relative-strength reading for this week, so the score is built from earnings, capital efficiency and valuation alone.

Ranked last: too little evidence (3 companies)

Under 60% of the evidence behind these scores is available, so they rank after every company above, whatever the score.

  1. 6KRM Ayurveda LtdKRMAYURVED · provisional · 38% evidence64.4out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 23.5/43.75 · Revenue — · PAT — · OPM change 12 pp · 32% evidenceCapital efficiency 26.5/31.25 · ROCE 35.3% (year to Mar 2026) · OPM 37.2% · 95% evidenceValuation 14.4/25 · P/E 18.7× · PEG — · 15% evidenceRelative strength: no reading this week · its 20 points are shared across the other threeExact sum: 23.5 + 26.5 + 14.4 = 64.4 (no relative-strength reading this week; its 20 points are shared across the other three) · What this means: Some evidence is missing, so the score is pulled toward the middle on purpose.
  2. 7Unihealth Hospitals LtdUNIHEALTH · quiet · provisional · 42% evidence53.5out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 17.7/35 · Revenue — · PAT — · OPM change −4 pp · 15% evidenceCapital efficiency 16.7/25 · ROCE 24.5% (year to Mar 2026) · OPM 33.9% · 57% evidenceValuation 10.2/20 · P/E 32.9× · PEG — · 15% evidenceRelative strength 8.9/20 · RS sector −0.7% · RS bench 6.3% · 1Y 53.1% · 100% evidence · 5 of 12 weeks aheadExact sum: 17.7 + 16.7 + 10.2 + 8.9 = 53.5 · What this means: Some evidence is missing, so the score is pulled toward the middle on purpose.
  3. 8Credent Connect N Care LtdCREDENT · provisional · 38% evidence50.5out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 21.0/43.75 · Revenue — · PAT — · OPM change 0 pp · 32% evidenceCapital efficiency 16.2/31.25 · ROCE 21.5% (quarter to Sep 2026) · OPM 13% · 95% evidenceValuation 13.3/25 · P/E 32.3× · PEG — · 15% evidenceRelative strength: no reading this week · its 20 points are shared across the other threeExact sum: 21 + 16.2 + 13.3 = 50.5 (no relative-strength reading this week; its 20 points are shared across the other three) · What this means: Some evidence is missing, so the score is pulled toward the middle on purpose.
How this score is built, and what the marks mean

Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led NIFTY 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read.

How have Healthcare Services share prices moved?

Park Medi World Ltd has the strongest one-year price move in Hospitals/Medical Services at +65.0%. Dr Agarwals Health Care Ltd leads on relative strength against the NIFTY, at +11.5%. 2 of 8 companies we track are ahead of the index on that measure (6 have no relative-strength reading yet). Every line covers 314 weekly closes through 13 November 2026.

Price and relative strength

Price · same starting point: Every company, the sector's own index and NIFTY 500 all start level on the left edge of the window, so only the distance between the lines counts: the highest line has risen the most since then, and the chart at the top of this page is drawn the same way. It opens on one year; the buttons beside it stretch that to three or five.

RS vs NIFTY 500: How far ahead of or behind NIFTY 500 each company has been running, measured against its own recent average of that comparison, so the flat line at zero IS NIFTY 500: above it the company is beating the market, below it the market is beating the company. It opens on one year.

RS vs sector: The same measure taken against Hospitals/Medical Services itself instead of the whole market, so the flat line at zero is the sector: above it the company is beating its own peers, which is the sharper test of the two. It opens on one year.

Biggest one-year moves

  1. 1Park Medi World LtdPARKHOSPS · ₹10,300 cr+65.0%1 year
  2. 2Unihealth Hospitals LtdUNIHEALTH · ₹844 cr+53.1%1 year
  3. 3Gujarat Kidney & Super Speciality LtdGKSL · ₹1,180 cr+51.6%1 year
  4. 4Nephrocare Health Services LtdNEPHROPLUS · ₹6,590 cr+45.0%1 year
  5. 5Dr Agarwals Health Care LtdAGARWALEYE · ₹17,500 cr+12.1%1 year

Strongest against NIFTY 500

  1. 1Dr Agarwals Health Care LtdAGARWALEYE · ₹17,500 cr+11.5%vs NIFTY 500
  2. 2Unihealth Hospitals LtdUNIHEALTH · ₹844 cr+6.3%vs NIFTY 500

Strongest against the sector itself

  1. 1Unihealth Hospitals LtdUNIHEALTH · ₹844 cr−0.7%vs sector

Why are Healthcare Services stocks moving?

Sector revenue has compounded from ₹553 crore in 2020 to ₹5,178 crore in 2026 and Σprofit from a small loss to ₹626 crore, most recently +36.7% year-on-year. The participation is broad (86% of names advancing, index stage agrees) even though the Σprofit contribution is concentrated in three names. In the week of 13 July 2026, 100% of 7 Hospitals/Medical Services companies were beating the Nifty 500, against 100% on 2 March 2026.

Hospitals/Medical Services: share of companies beating the Nifty 500, and above their 200-day average, to 13 July 2026, last sector review

  • Beating the Nifty 500 100%
  • Above the 200-day average 100%
Hospitals/Medical Services: share of companies beating the Nifty 500, and above their 200-day average, to 13 July 2026, last sector review
WeekBeating the Nifty 500Above the 200-day average
2 Mar 2026100%83.3%
9 Mar 202650%83.3%
16 Mar 2026100%83.3%
23 Mar 2026100%50%
30 Mar 2026100%80%
6 Apr 202650%85.7%
13 Apr 202650%85.7%
20 Apr 202650%85.7%
27 Apr 202650%85.7%
4 May 2026100%100%
11 May 2026100%85.7%
18 May 2026100%100%
25 May 2026100%100%
1 Jun 2026100%100%
8 Jun 202650%85.7%
15 Jun 2026100%100%
22 Jun 2026100%100%
29 Jun 2026100%100%
6 Jul 2026100%100%
13 Jul 2026100%100%

From our industry review of 19 July 2026. A newer review (10 October 2026) did not cover Hospitals/Medical Services, so this is the latest we have.

What is changing in Healthcare Services stocks?

This is the written read behind the Hospitals/Medical Services figures above: what is actually happening in the industry, in words, with the evidence each claim rests on. It is dated 28 Jul 2026, so the words are older than the numbers. 3 themes are live here.

The verdict is Cautious. While growth metrics are high, regulatory penalties and lack of guidance introduce uncertainty. The operating leverage inflection depends on occupancy improving to 70%+.

The Hospitals/Medical Services sector analysis for the week ending 17 July 2026 centers on Gujarat Kidney & Super Speciality Ltd (GKSL). The constituent reported Q4 FY26 total income of ₹31.29 crore, marking a 218.3% YoY increase from ₹9.83 crore in Q4FY25. Profit after tax surged 259.7% YoY to ₹4.82 crore.

How old this read is: OLD: this read comes from our Hospitals/Medical Services sector brief dated 28 Jul 2026, about 4 months ago. The page says so rather than dressing it up, and a fresh sector dive replaces it the day it runs.

What is live in this sector right now

Live theme, Severity, Evidence on file
Live themeSeverityEvidence on file
Company paid ₹6,60,800 penalty to exchange and BSE for failing to submit quarterly financial results within prescribed timelines under Regulation 33 of SEBI LODR 2015, with additional…Named for Gujarat Kidney & Super Specialitymedium“Company paid ₹6,60,800 penalty to exchange and BSE for failing to submit quarterly financial results within prescribed timelines under Regulation 33 of SEBI LODR 2015, with additional ₹20,000 fine for board meeting…” Company stated no additional financial impact expected from regulatory action and penalty settlement closes the matter with both exchanges.
Company faces heavy reliance on key doctors creating attrition risk, with revenue concentrated in IPD (73%) and Gujarat region limiting diversification.Named for Gujarat Kidney & Super Specialitymedium“Company faces heavy reliance on key doctors creating attrition risk, with revenue concentrated in IPD (73%) and Gujarat region limiting diversification.”
Multiple regulatory violations cited including delay in furnishing prior intimation about Board of Directors meeting, contravening listing requirements.Named for Gujarat Kidney & Super Specialitylow“Multiple regulatory violations cited including delay in furnishing prior intimation about Board of Directors meeting, contravening listing requirements.” Company stated levy of fines has no impact on financial, operational, or any other activities.

Sources: our Hospitals/Medical Services sector brief, 28 Jul 2026 · company earnings-call transcripts.

Which Healthcare Services companies have the most revenue, and which grow fastest?

Dr Agarwals Health Care Ltd has the highest Revenue among the 8 Hospitals/Medical Services companies compared here, at ₹2,363 crore. Park Medi World Ltd is next at ₹1,857 crore. Gujarat Kidney & Super Speciality Ltd has the highest Revenue growth at the 100% top of the scoring scale, so level and change sit with different companies.

What the numbers say: Dr Agarwals Health Care Ltd is the largest at ₹2,363 crore, 27.2% ahead of Park Medi World Ltd. Gujarat Kidney & Super Speciality Ltd's growth is capped at 100% on the scoring scale; the full change over the last 12 months is 153.6% from a ₹126 crore base, with 10 reported quarters out of the last 20. Fast growth from a smaller base is not yet the same as proven size.

Dr Agarwals Health Care Ltd · ₹2,363 croreLeader
27.2% versus #2 · Park Medi World LtdGap
8/8 recent comparable periodsPersistence
5/8 companies · 64 observationsCoverage

What this means: Dr Agarwals Health Care Ltd is the size to compare against; Gujarat Kidney & Super Speciality Ltd is the one growing fastest. The faster grower has to keep that growth and turn it into margin and returns before it counts as more than a fast start.

This conclusion weakens if: Dr Agarwals Health Care Ltd's growth falls below Gujarat Kidney & Super Speciality Ltd's for two consecutive comparable reports while operating margin also compresses.

Revenue is compared on a common reported-currency basis. Growth is year-on-year, so seasonality does not masquerade as progress.

Revenue · company comparison

Revenue · largest

  1. 1Dr Agarwals Health Care LtdAGARWALEYE₹2,360 cr
  2. 2Park Medi World LtdPARKHOSPS₹1,860 cr
  3. 3Nephrocare Health Services LtdNEPHROPLUS₹1,110 cr
  4. 4Gujarat Kidney & Super Speciality LtdGKSL₹126 cr
  5. 5Gaudium IVF and Women Health LtdGAUDIUMIVF₹112 cr

Revenue growth · fastest growers

All-company data · latest reported quarter

In every all-company table on this page, each figure is the company’s latest single reported quarter. The rankings above them use trailing-twelve-month or current-market values, so a company can legitimately show a different number in each.

Revenue, every company
CompanyRevenueRevenue growthReported
Dr Agarwals Health Care Ltd AGARWALEYE₹655 cr31%Sep 2026
Park Medi World Ltd PARKHOSPS₹511 cr25%Sep 2026
Nephrocare Health Services Ltd NEPHROPLUS₹303 cr23%Sep 2026
Credent Connect N Care Ltd CREDENT unverified₹138 cr53%Sep 2026
Unihealth Hospitals Ltd UNIHEALTH₹65 cr16%Mar 2026
Gujarat Kidney & Super Speciality Ltd GKSL₹38.1 cr195%Sep 2026
Gaudium IVF and Women Health Ltd GAUDIUMIVF₹37.4 cr18%Sep 2026
KRM Ayurveda Ltd KRMAYURVED unverified₹32.3 cr31%Jun 2026

Revenue shows both size and speed. A large company can absorb shocks and pay for wide distribution; faster growth can mean market-share gains, new capacity or stronger demand. The best sign is usually growth that lasts without hurting margins and returns.

What to watch

Watch the next two reported quarters for growth persistence, margin conversion and whether the leader is gaining share without stretching working capital.

Which Healthcare Services companies keep the most from each ₹100 of sales?

KRM Ayurveda Ltd has the highest OPM among the 8 Hospitals/Medical Services companies compared here, at 37.2%. Gaudium IVF and Women Health Ltd is next at 36%. The same company also has the highest Margin change, at +12 percentage points. 8 of 8 companies report a comparable reading, the latest through Jun 2026.

What the numbers say: KRM Ayurveda Ltd leads both opm at 37.2% and margin change at +12 percentage points.

KRM Ayurveda Ltd · 37.2%Leader
3.3% versus #2 · Gaudium IVF and Women Health LtdGap
2/2 recent comparable periodsPersistence
8/8 companies · 66 observationsCoverage

What this means: KRM Ayurveda Ltd sets the level to compare against; the company improving fastest needs another report to confirm the change.

This conclusion weakens if: The next two comparable reports reverse the current margin change signal.

Operating margin compares operating profit with revenue. Improvement is measured in percentage points, not percentage growth.

Operating margin · company comparison

OPM, by reported quarter

  • KRM Ayurveda 37%
  • Gaudium IVF and Women Health 36%
  • Unihealth Hospitals 34%
  • Dr Agarwals Health Care 27%
  • Gujarat Kidney & Super Speciality 27%
OPM, by reported quarter
QuarterKRM AyurvedaGaudium IVF and Women HealthUnihealth HospitalsDr Agarwals Health CareGujarat Kidney & Super Speciality
Mar 2020—————
Mar 2021—————
Mar 2022—————
Mar 2023—————
Sep 2023——32%26%—
Dec 2023———27%—
Mar 2024——39%31%—
Jun 2024—36%—26%42%
Sep 2024—40%35%26%52%
Dec 2024—39%—27%39%
Mar 202521%32%38%28%27%
Jun 202525%29%—26%56%
Sep 202527%43%48%27%40%
Dec 2025—27%—27%30%
Mar 202634%40%34%29%21%
Jun 202637%13%—28%24%
Sep 2026—36%—27%27%

Margin change, by reported quarter

  • KRM Ayurveda +12.0 pp
  • Gaudium IVF and Women Health −7.4 pp
  • Unihealth Hospitals −4.0 pp
  • Dr Agarwals Health Care 0.0 pp
  • Gujarat Kidney & Super Speciality −12.8 pp
Margin change, by reported quarter
QuarterKRM AyurvedaGaudium IVF and Women HealthUnihealth HospitalsDr Agarwals Health CareGujarat Kidney & Super Speciality
Mar 2020—————
Mar 2021—————
Mar 2022—————
Mar 2023—————
Sep 2023—————
Dec 2023—————
Mar 2024—————
Jun 2024—————
Sep 2024——+3.0 pp+0.5 pp—
Dec 2024———0.0 pp—
Mar 2025——−1.0 pp−3.0 pp—
Jun 2025—−7.2 pp—0.0 pp+14.6 pp
Sep 2025—+3.4 pp+13.0 pp+1.0 pp−12.1 pp
Dec 2025—−12.5 pp—0.0 pp−9.3 pp
Mar 2026+13.1 pp+7.7 pp−4.0 pp+1.0 pp−6.1 pp
Jun 2026+12.0 pp−16.5 pp—+2.0 pp−32.1 pp
Sep 2026—−7.4 pp—0.0 pp−12.8 pp

8 of 8 companies report OPM, 8 of 8 margin change.

OPM · highest

  1. 1KRM Ayurveda Ltd unverifiedKRMAYURVED37%
  2. 2Gaudium IVF and Women Health LtdGAUDIUMIVF36%
  3. 3Unihealth Hospitals LtdUNIHEALTH · older report34%
  4. 4Dr Agarwals Health Care LtdAGARWALEYE27%
  5. 5Gujarat Kidney & Super Speciality LtdGKSL27%

Margin change · fastest expanders

  1. 1KRM Ayurveda Ltd unverifiedKRMAYURVED+12.0 pp
  2. 2Dr Agarwals Health Care LtdAGARWALEYE0.0 pp
  3. 3Credent Connect N Care Ltd unverifiedCREDENT0.0 pp
  4. 4Unihealth Hospitals LtdUNIHEALTH · older report−4.0 pp
  5. 5Nephrocare Health Services LtdNEPHROPLUS−5.0 pp

All-company data · latest reported quarter

Operating margin, every company
CompanyOPMMargin changeReported
KRM Ayurveda Ltd KRMAYURVED unverified37%+12.0 ppJun 2026
Gaudium IVF and Women Health Ltd GAUDIUMIVF36%−7.4 ppSep 2026
Unihealth Hospitals Ltd UNIHEALTH34%−4.0 ppMar 2026
Dr Agarwals Health Care Ltd AGARWALEYE27%0.0 ppSep 2026
Gujarat Kidney & Super Speciality Ltd GKSL27%−12.8 ppSep 2026
Nephrocare Health Services Ltd NEPHROPLUS21%−5.0 ppSep 2026
Park Medi World Ltd PARKHOSPS20%−7.0 ppSep 2026
Credent Connect N Care Ltd CREDENT unverified13%0.0 ppSep 2026

What to watch

Watch whether the next two comparable periods confirm the current margin change rather than reversing it.

Which Healthcare Services companies earn the most profit?

Park Medi World Ltd has the highest Net profit among the 8 Hospitals/Medical Services companies compared here, at ₹273 crore. Dr Agarwals Health Care Ltd is next at ₹206 crore. Gujarat Kidney & Super Speciality Ltd has the highest Profit growth at 68.2%, so level and change sit with different companies.

What the numbers say: Park Medi World Ltd earns the most, ₹273 crore of profit over the last 12 months, 32.5% above Dr Agarwals Health Care Ltd. Gujarat Kidney & Super Speciality Ltd shows 68.2% growth from a profit base of ₹20 crore. A fast rate from a small base matters less than a large profit that keeps coming.

Park Medi World Ltd · ₹273 croreLeader
32.5% versus #2 · Dr Agarwals Health Care LtdGap
3/4 recent comparable periodsPersistence
5/8 companies · 64 observationsCoverage

What this means: Park Medi World Ltd sets the level to compare against; the company improving fastest needs another report to confirm the change.

This conclusion weakens if: The next two comparable reports reverse the current profit growth signal.

Net profit is the residual after operating costs, interest and tax. Growth off a loss or near-zero base is excluded from the fastest-grower rank.

Net profit · company comparison

Net profit · largest

  1. 1Park Medi World LtdPARKHOSPS₹273 cr
  2. 2Dr Agarwals Health Care LtdAGARWALEYE₹206 cr
  3. 3Nephrocare Health Services LtdNEPHROPLUS₹128 cr
  4. 4Gaudium IVF and Women Health LtdGAUDIUMIVF₹23.2 cr
  5. 5Gujarat Kidney & Super Speciality LtdGKSL₹20.4 cr

Profit growth · fastest growers

All-company data · latest reported quarter

Net profit, every company
CompanyNet profitProfit growthReported
Dr Agarwals Health Care Ltd AGARWALEYE₹57 cr58%Sep 2026
Park Medi World Ltd PARKHOSPS₹54 cr−32%Sep 2026
Nephrocare Health Services Ltd NEPHROPLUS₹34 cr33%Sep 2026
Unihealth Hospitals Ltd UNIHEALTH₹17 cr−5.6%Mar 2026
Credent Connect N Care Ltd CREDENT unverified₹15 cr88%Sep 2026
Gaudium IVF and Women Health Ltd GAUDIUMIVF₹9.4 cr0.3%Sep 2026
KRM Ayurveda Ltd KRMAYURVED unverified₹9.1 cr124%Jun 2026
Gujarat Kidney & Super Speciality Ltd GKSL₹6.6 cr129%Sep 2026

What to watch

Watch whether the next two comparable periods confirm the current profit growth rather than reversing it.

Which Healthcare Services companies earn the best return on capital?

KRM Ayurveda Ltd has the highest ROCE among the 8 Hospitals/Medical Services companies compared here, at 35.3%. Gaudium IVF and Women Health Ltd is next at 29.5%. Dr Agarwals Health Care Ltd has the highest ROCE change at +1 percentage points, so level and change sit with different companies.

What the numbers say: KRM Ayurveda Ltd leads ROCE at 35.3%, 5.8 percentage points above Gaudium IVF and Women Health Ltd. A high return reported once may be one good year; a high return reported year after year shows a lasting business.

KRM Ayurveda Ltd · 35.3%Leader
19.7% versus #2 · Gaudium IVF and Women Health LtdGap
Not enough historyPersistence
8/8 companies · 27 observationsCoverage

What this means: KRM Ayurveda Ltd sets the level to compare against; the company improving fastest needs another report to confirm the change.

This conclusion weakens if: The next two comparable reports reverse the current roce change signal.

ROCE asks how much operating return the business earns on the capital employed. Direction matters, but a single exceptional year should not be mistaken for durability.

Return on capital · company comparison

Withheld from this chart: Dr Agarwals Health Care Ltd (AGARWALEYE): its two data sources disagree by up to 31% on reported income across 11 comparable periods, so its derived ratios are withheld; Park Medi World Ltd (PARKHOSPS): its two data sources disagree by up to 34% on reported income across 7 comparable periods, so its derived ratios are withheld; Unihealth Hospitals Ltd (UNIHEALTH): its two data sources disagree by up to 46% on reported income across 6 comparable periods, so its derived ratios are withheld. A figure two sources cannot agree on is not drawn, the gap is a decision, not missing data.

ROCE · highest

  1. 1KRM Ayurveda Ltd unverifiedKRMAYURVED35%
  2. 2Gaudium IVF and Women Health LtdGAUDIUMIVF30%
  3. 3Credent Connect N Care Ltd unverifiedCREDENT22%

ROCE change · fastest improvers

  1. 1Nephrocare Health Services LtdNEPHROPLUS−3.4 pp
  2. 2KRM Ayurveda Ltd unverifiedKRMAYURVED−5.0 pp

All-company data · latest reported quarter

Return on capital, every company
CompanyROCEROCE changeReported
Credent Connect N Care Ltd CREDENT unverified22%−18.3 ppSep 2026
Gaudium IVF and Women Health Ltd GAUDIUMIVF18%−47.7 ppSep 2026
Nephrocare Health Services Ltd NEPHROPLUS13%−3.4 ppSep 2026
Gujarat Kidney & Super Speciality Ltd GKSL9.3%−31.8 ppSep 2026

What to watch

Watch whether the next two comparable periods confirm the current roce change rather than reversing it.

How are Healthcare Services stocks valued against growth and quality?

Nephrocare Health Services Ltd has the lowest PEG among the 8 Hospitals/Medical Services companies compared here, at 1.22×. KRM Ayurveda Ltd has the lowest P/E at 18.7×, so level and change sit with different companies. 1 of 8 companies report a comparable reading, the latest through Sep 2026.

What the numbers say: That would need today's multiple, the company's own history and steady growth to agree.

Nephrocare Health Services Ltd · 1.22×Leader
Not enough peersGap
0/4 recent comparable periodsPersistence
1/8 companies · 0 observationsCoverage

What this means: A low valuation is a reason to look closer at the business, not a conclusion on its own.

This conclusion weakens if: The next two comparable reports reverse the current p/e signal.

PEG is shown only when earnings are positive and three-year EPS growth is between 5% and 60%. It is worked out the same way every time, as the P/E on the last 12 months of reported earnings divided by that growth rate, never on expected earnings. On Indian companies it is shown only where the two data feeds agreed. Where any of that fails the ratio is left out rather than printed: a P/E divided by a loss, or by growth measured off a tiny base, is a number that looks precise and means nothing.

Valuation · company comparison

P/E, by reported quarter

P/E, by reported quarter
QuarterNephrocare Health Services
Mar 2020—
Mar 2021—
Mar 2022—
Mar 2023—
Sep 2023—
Dec 2023—
Mar 2024—
Jun 2024—
Sep 2024—
Dec 2024—
Mar 2025—
Jun 2025—
Sep 2025—
Dec 202570.1×
Mar 202675.8×
Jun 202688.5×
Sep 202678.0×

1 of 8 companies report PEG, 8 of 8 P/E.

PEG · lowest PEG

P/E · lowest P/E

  1. 1KRM Ayurveda Ltd unverifiedKRMAYURVED18.7×
  2. 2Gaudium IVF and Women Health LtdGAUDIUMIVF30.4×
  3. 3Credent Connect N Care Ltd unverifiedCREDENT32.3×
  4. 4Unihealth Hospitals LtdUNIHEALTH · older report32.9×
  5. 5Park Medi World LtdPARKHOSPS40.1×

All-company data · latest reported quarter

Valuation, every company
CompanyPEGP/EReported
Nephrocare Health Services Ltd NEPHROPLUS1.278.0×Sep 2026
Dr Agarwals Health Care Ltd AGARWALEYE—107.8×Sep 2026
Park Medi World Ltd PARKHOSPS—42.8×Sep 2026
Gujarat Kidney & Super Speciality Ltd GKSL—89.2×Sep 2026
Unihealth Hospitals Ltd UNIHEALTH—24.8×Mar 2026
Gaudium IVF and Women Health Ltd GAUDIUMIVF—35.0×Sep 2026
Credent Connect N Care Ltd CREDENT unverified—38.9×Sep 2026
KRM Ayurveda Ltd KRMAYURVED unverified—27.4×Jun 2026

What to watch

Watch whether the next two comparable periods confirm the current p/e rather than reversing it.

Which stock lists do Healthcare Services companies appear on?

Hospitals/Medical Services companies show up on 7 of our India lists. The most are on the healthcare & hospital stocks list (6 companies).

What can make this comparison misleading?

This Hospitals/Medical Services comparison names 8 specific ways its own evidence can mislead, all listed below. 1 of the 8 companies reports on an older date than the sector's freshest reporters, so its rank is marked stale. 2 use at least one figure from a second source we could not check.

Keep these limits visible

  • A high growth rate can come from a very small starting figure. The page keeps level and change separate for that reason.
  • A high ROCE can be temporary, or look high because the capital base is small. It is best read beside margin, cash flow and how much is spent back on the business.
  • The 4-Factor Sector Score ranks published data only. Management quality, upcoming events and risks are not part of it.
  • An “all companies” line chart preserves completeness, but rank changes should be checked against reporting dates before drawing a conclusion.
  • 1 company has an older fundamental reporting date than the sector’s freshest reporters; its rank carries a stale marker.
  • 2 companies draw at least one figure from a second data source that does not cover enough of the same periods to check against the main one; they are marked unverified wherever those figures appear.
  • 3 companies are missing from the second-source figures on purpose: the two sources disagree, so nothing from the second is drawn. Those rows have less evidence; that does not make the business weaker.
  • Thin comparisons: Valuation have fewer than three usable current readings.

How was this comparison built?

This comparison is built from the reported filings of 8 Hospitals/Medical Services companies, normalized to a common ₹ scale and a shared quarter axis of up to 17 quarters each. Fundamentals run through Sep 2026 and market data through 13 November 2026.

FundamentalsThrough Sep 2026 · up to 17 quarters per company
Market dataThrough 13 November 2026 · weekly price and relative-strength history
Derived metricsGrowth, changes and PEG are calculated only when their inputs are comparable.
Score confidenceMissing and old evidence lowers confidence and pulls the 0 to 100 score toward the middle.
Source standing3 cross-checked · 2 unverified · 3 withheld, of 8 graded companies.

2 of 8 companies draw at least one figure from a second data feed that could not be cross-checked against the primary source, because the two do not share enough reported history to compare. Those figures are marked unverified wherever they appear.

3 of 8 companies have a second data feed that is known to disagree with the primary source, so nothing from it is drawn: Dr Agarwals Health Care Ltd (AGARWALEYE): its two data sources disagree by up to 31% on reported income across 11 comparable periods, so its derived ratios are withheld; Park Medi World Ltd (PARKHOSPS): its two data sources disagree by up to 34% on reported income across 7 comparable periods, so its derived ratios are withheld; Unihealth Hospitals Ltd (UNIHEALTH): its two data sources disagree by up to 46% on reported income across 6 comparable periods, so its derived ratios are withheld.

How a second data feed is admitted, and what happens when it disagrees

A second feed is read only after its reported income is matched against the primary source on at least three overlapping periods. Where the two agree, the figures are simply used. Where there is too little shared history to compare, the figures are still drawn, they are the only evidence there is, and marked unverified everywhere they appear. Where the two are known to disagree, nothing from the second feed is drawn and the affected company is named under the chart it is missing from.

What else do people ask about Healthcare Services stocks?

These 24 answers restate the Hospitals/Medical Services comparison above in question form. Every one is computed from the same 8 companies and the same reported filings as the rankings and charts, current through Sep 2026. Price and relative-strength answers run through 13 November 2026. Nothing here is estimated, and none of it is a recommendation.

Is the Healthcare Services sector outperforming NIFTY 500?

Hospitals/Medical Services has done better than the NIFTY 500 by 106.6% over 52 weeks, but is 5.7% behind over the last 13 weeks.

1 of 8 companies we track is beating the NIFTY on relative strength (how a share price has done against the index over recent months) (6 have no relative-strength reading yet).

Which Healthcare Services company is largest by revenue?

Dr Agarwals Health Care Ltd leads with revenue of ₹2,363 crore, based on 5 of 8 comparable companies through Sep 2026.

Which Healthcare Services company is growing fastest?

Gujarat Kidney & Super Speciality Ltd has the fastest current revenue growth at 100%, across 5 of 8 comparable companies.

Which Healthcare Services company has the strongest 4-Factor Sector Score?

Dr Agarwals Health Care Ltd ranks first at 58.9 out of 100, with 60.3% of the evidence available. The score ranks published data; it is not a recommendation.

Which Healthcare Services company has the lowest comparable PEG?

Nephrocare Health Services Ltd has the lowest comparable PEG at 1.22, among 1 of 8 companies whose earnings and growth are steady enough for the ratio to mean anything.

How much history does this Healthcare Services comparison include?

The page compares up to 17 reported quarters per company for fundamentals, returns and valuation, ending Sep 2026. Missing observations remain blank rather than being estimated.

How is the 4-Factor Sector Score calculated?

The four parts add up directly: growth and earnings up to 35 points, capital efficiency up to 25, valuation up to 20, and relative strength up to 20. Missing or old evidence moves only that part toward the middle.

Is there a Nifty Healthcare Services index?

The exchange runs Nifty indices for several broad sectors, such as Nifty Bank, Nifty IT and Nifty Pharma, but not for every smaller group on this site.

Whether or not an official Nifty index covers Hospitals/Medical Services, this page builds its own equal-weight basket of 8 listed Hospitals/Medical Services companies: one company, one vote, whatever its size, so no single large company dominates. Figures are as of Sep 2026.

Which are the best Healthcare Services stocks in India?

Ranked by this page's four-factor score, Dr Agarwals Health Care Ltd comes first among 8 listed Hospitals/Medical Services companies, followed by Gujarat Kidney & Super Speciality Ltd. That is a ranking of published data (earnings, quality, valuation and share-price behaviour as of Sep 2026), not a recommendation.

How many Healthcare Services stocks are listed in India?

This comparison covers 8 listed Hospitals/Medical Services companies in India, each above the size floor the site applies, with 20 quarters of reported figures per company where the filings exist. The full ranked list is on this page, as of Sep 2026.

Which Healthcare Services company is the biggest?

Dr Agarwals Health Care Ltd is the largest, with revenue of ₹2,363 crore over the last 12 months, ahead of Park Medi World Ltd at ₹1,857 crore. That covers 5 of 8 companies with comparable reporting through Sep 2026.

Which Healthcare Services company has the best profit margins?

KRM Ayurveda Ltd has the highest operating margin at 37.2%, from 8 of 8 comparable companies. KRM Ayurveda Ltd shows the biggest recent improvement, at +12 percentage points. A high margin matters most when it is steady or rising, not when it is at a peak.

Which Healthcare Services company makes the most profit?

Park Medi World Ltd earns the most, at ₹273 crore of net profit over the last 12 months, from 5 of 8 comparable companies.

Gujarat Kidney & Super Speciality Ltd has the fastest profit growth at 68.2%, though growth off a small or recovering profit base overstates how much has actually changed.

Which Healthcare Services company earns the highest return on capital?

KRM Ayurveda Ltd leads on return on capital employed at 35.3%, across 8 of 8 companies. A high return that repeats for years shows a lasting business, while a single high reading can come from a small capital base or one good year.

Which Healthcare Services stock has the lowest PEG ratio?

On PEG (where a lower number means a lower price for what the company earns), Nephrocare Health Services Ltd has the lowest at 1.22×.

Only 1 of 8 companies have earnings and growth steady enough for the ratio to mean anything, so this is not a ranking of the whole industry. A low multiple is a reason to look closer at the business, not a conclusion on its own.

Is the Healthcare Services sector beating the market?

Hospitals/Medical Services has done better than the NIFTY 500 by 106.6% over the last 52 weeks, but is 5.7% behind over the last 13 weeks, measured on an equal-weight index of its current members.

Inside the sector, 1 of the 8 companies we track is beating the market on their own (6 have no relative-strength reading yet). Sector strength does not transfer evenly to every stock in it.

Which Healthcare Services stock has the strongest price momentum?

Dr Agarwals Health Care Ltd has the strongest relative strength against the NIFTY 500, meaning its share price has done best against the index. A price can move well before the business results back it up, and sometimes without them.

Which Healthcare Services company has the highest 4-Factor score?

Dr Agarwals Health Care Ltd scores 58.9 out of 100, with 60.3% of the evidence available, from 28.6 points on growth and earnings, 9.3 on capital efficiency, 8.5 on valuation and 12.5 on relative strength.

It ranks published data only; management quality, upcoming events and risks are not part of the score.

How many Healthcare Services companies does this comparison cover, and over what period?

This comparison covers 8 listed companies over up to 17 reported quarters of fundamentals, ending Sep 2026, plus weekly price and relative-strength history. Membership is the full sector list, nothing is dropped for having thin data.

What is the total market cap of the Healthcare Services sector?

The 8 Hospitals/Medical Services companies on this page carry ₹38,454 crore of combined market value. Dr Agarwals Health Care Ltd is the largest at ₹17,545 crore, about 46% of the sector's total on its own. Market value moves with price, so this reading is dated 13 November 2026.

What is the Healthcare Services sector's P/E ratio?

The median price-to-earnings ratio across the 8 Hospitals/Medical Services companies on this page is 40.1×, measured on the 8 that report a comparable figure. A sector-level history for this multiple is not held here, so this is a cross-section of today, not a comparison with the sector’s own past.

Figures are as of 13 November 2026.

How is the Healthcare Services sector performing?

1 of the 8 Hospitals/Medical Services companies we track is doing better than the NIFTY 500 on relative strength (how a share price has done against the index over recent months) (6 have no relative-strength reading yet).

The sector itself is 106.6% ahead of NIFTY 500 over 52 weeks on an equal-weight index of its current members.

Why are some values on this page blank?

A blank means that company did not report a comparable figure for that period, so nothing is shown. Missing figures are never estimated, copied forward or swapped for a similar-looking line, and a company with missing evidence has its score pulled toward the middle rather than scored as bad.

Is this advice?

No, every figure here is worked out by code from company filings and market data, for research. It does not account for your situation and is not a substitute for advice from a registered adviser.

More lists

Every Sector Alpha list, grouped

Every India sector against its index · What changed this week · Plain-text data
Sector Alpha, written by code from the published numbers · Fundamentals through Sep 2026 · Prices through 13 November 2026. Every ranking is worked out by code from reported figures. Missing values stay missing.

X · Instagram · YouTube · About · Newsletter · Newsletter archive
This is research, not advice. We’re not SEBI-registered.